Synthesis and Anti-Ischemic Activity in Rats of Substituted N-Benzyl 1,2,5-Trimethyl-, 2,2,6,6-Tetramethylpiperidyl-, and Tropylamines

I. B. Tsorin; M. B. Vititnova; V. N. Stolyaruk; L. M. Kostochka; S. A. Kryzhanovskii

doi:10.1007/s11094-019-01963-8

Synthesis and Anti-Ischemic Activity in Rats of Substituted N-Benzyl 1,2,5-Trimethyl-, 2,2,6,6-Tetramethylpiperidyl-, and Tropylamines

Authors: Tsorin I.B.¹, Vititnova M.B.¹, Stolyaruk V.N.¹, Kostochka L.M.¹, Kryzhanovskii S.A.¹
Affiliations:
1. V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences
Issue: Vol 53, No 2 (2019)
Pages: 113-117
Section: Article
URL: https://journals.rcsi.science/0091-150X/article/view/245626
DOI: https://doi.org/10.1007/s11094-019-01963-8
ID: 245626

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription Access

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

Series of benzylidene and benzyl derivatives of 1,2,5-trimethyl-, 2,2,6,6-tetramethylpiperidyl-, and tropylamines were synthesized and screened for anti-ischemic activity in rats. The lead compound was identified as 2,2,6,6-tetramethyl-N-(3,4,5-trimethoxybenzyl)piperidin-4-amine, the anti-ischemic activity of which was statistically significantly greater than that of the reference drug trimetazidine in a myocardial subendocardial ischemia model.